A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612

被引：8

作者：

Assouline, Sarit ^{[1
]}

Michaelis, Laura C. ^{[2
]}

Othus, Megan ^{[3
]}

Hay, Annette E. ^{[4
]}

Walter, Roland B. ^{[5
]}

Jacoby, Meagan A. ^{[6
]}

Schroeder, Mark A. ^{[6
]}

Uy, Geoffrey L. ^{[6
]}

Law, Lisa Y. ^{[7
]}

Cheema, Faisal ^{[8
]}

Sweet, Kendra L. ^{[9
]}

Asch, Adam S. ^{[10
]}

Liu, Jijun ^{[11
]}

Moseley, Anna B. ^{[2
]}

Maher, Tracy ^{[12
]}

Kingsbury, Laura L. ^{[12
]}

Fang, Min ^{[5
]}

Radich, Jerald ^{[5
]}

Little, Richard F. ^{[13
]}

Erba, Harry P. ^{[14
]}

机构：

[1] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada

[2] Med Coll Wisconsin, Milwaukee, WI USA

[3] SWOG Stat & Data Management Ctr, Seattle, WA USA

[4] Queens Univ, Kingston, ON, Canada

[5] Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[6] Washington Univ, Sch Med, St Louis, MO USA

[7] Kaiser Permanente NCAL, Roseville, CA USA

[8] Kaiser Permanente, Santa Clara, CA USA

[9] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[10] Univ Oklahoma HSC, Oklahoma City, OK USA

[11] Illinois Canc Care Heartland NCORP, Peoria, IL USA

[12] SWOG Data Operat Ctr, Canc Res & Biostat, Seattle, WA USA

[13] Natl Canc Inst, Canc Therapy & Evaluat Program CTEP, Bethesda, MD USA

[14] Duke Univ, Duke Canc Inst, Med Ctr, Durham, NC USA

来源：

LEUKEMIA & LYMPHOMA | 2023年 / 64卷 / 02期

基金：

美国国家卫生研究院;

关键词：

CONVENTIONAL-CARE-REGIMENS; THERAPY;

D O I：

10.1080/10428194.2022.2148212

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：473 / 477

页数：5

共 18 条

[1] Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti-PD-1-based therapy [J].

Abbas, Hussein A. ;

Alaniz, Zoe ;

Mackay, Sean ;

Cyr, Matthew ;

Zhou, Jing ;

Issa, Ghayas C. ;

Alfayez, Mansour ;

Matthews, Jairo ;

Kornblau, Steven M. ;

Jabbour, Elias ;

Garcia-Manero, Guillermo ;

Konopleva, Marina ;

Andreeff, Michael ;

Daver, Naval .

BLOOD ADVANCES, 2021, 5 (22) :4569-4574

[2] Novel Approaches to Acute Myeloid Leukemia Immunotherapy [J].

Beyar-Katz, Ofrat ;

Gill, Saar .

CLINICAL CANCER RESEARCH, 2018, 24 (22) :5502-5515

[3] Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndrome [J].

Chien, Kelly S. ;

Kim, Kunhwa ;

Nogueras-Gonzalez, Graciela M. ;

Borthakur, Gautam ;

Naqvi, Kiran ;

Daver, Naval G. ;

Montalban-Bravo, Guillermo ;

Cortes, Jorge E. ;

DiNardo, Courtney D. ;

Jabbour, Elias ;

Alvarado, Yesid ;

Andreeff, Michael ;

Bose, Prithviraj ;

Jain, Nitin ;

Kadia, Tapan M. ;

Huang, Xuelin ;

Sheppard, Kimberly B. ;

Klingner-Winton, Cheri ;

Pierce, Sherry A. ;

Dong, Xiao Qin ;

Soltysiak, Kelly A. ;

Kantarjian, Hagop M. ;

Garcia-Manero, Guillermo .

BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) :378-387

[4] Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study [J].

Daver, Naval ;

Garcia-Manero, Guillermo ;

Basu, Sreyashi ;

Boddu, Prajwal C. ;

Alfayez, Mansour ;

Cortes, Jorge E. ;

Konopleva, Marina ;

Ravandi-Kashani, Farhad ;

Jabbour, Elias ;

Kadia, Tapan ;

Nogueras-Gonzalez, Graciela M. ;

Ning, Jing ;

Pemmaraju, Naveen ;

DiNardo, Courtney D. ;

Andreeff, Michael ;

Pierce, Sherry A. ;

Gordon, Tauna ;

Kornblau, Steven M. ;

Flores, Wilmer ;

Alhamal, Zainab ;

Bueso-Ramos, Carlos ;

Jorgensen, Jeffrey L. ;

Patel, Keyur P. ;

Blando, Jorge ;

Allison, James P. ;

Sharma, Padmanee ;

Kantarjian, Hagop .

CANCER DISCOVERY, 2019, 9 (03) :370-383

[5] Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes [J].

Daver, Naval ;

Boddu, Prajwal ;

Garcia-Manero, Guillermo ;

Yadav, Shalini Singh ;

Sharman, Padmanee ;

Allison, James ;

Kantarjian, Hagop .

LEUKEMIA, 2018, 32 (05) :1094-1105

[6] Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia [J].

DiNardo, C. D. ;

Jonas, B. A. ;

Pullarkat, V. ;

Thirman, M. J. ;

Garcia, J. S. ;

Wei, A. H. ;

Konopleva, M. ;

Doehner, H. ;

Letai, A. ;

Fenaux, P. ;

Koller, E. ;

Havelange, V. ;

Leber, B. ;

Esteve, J. ;

Wang, J. ;

Pejsa, V. ;

Hajek, R. ;

Porkka, K. ;

Illes, A. ;

Lavie, D. ;

Lemoli, R. M. ;

Yamamoto, K. ;

Yoon, S. -S. ;

Jang, J. -H. ;

Yeh, S. -P. ;

Turgut, M. ;

Hong, W. -J. ;

Zhou, Y. ;

Potluri, J. ;

Pratz, K. W. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) :617-629

[7] Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].

Doehner, Hartmut ;

Estey, Elihu ;

Grimwade, David ;

Amadori, Sergio ;

Appelbaum, Frederick R. ;

Buechner, Thomas ;

Dombret, Herve ;

Ebert, Benjamin L. ;

Fenaux, Pierre ;

Larson, Richard A. ;

Levine, Ross L. ;

Lo-Coco, Francesco ;

Naoe, Tomoki ;

Niederwieser, Dietger ;

Ossenkoppele, Gert J. ;

Sanz, Miguel ;

Sierra, Jorge ;

Tallman, Martin S. ;

Tien, Hwei-Fang ;

Wei, Andrew H. ;

Lowenberg, Bob ;

Bloomfield, Clara D. .

BLOOD, 2017, 129 (04) :424-447

[8] International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts [J].

Dombret, Herve ;

Seymour, John F. ;

Butrym, Aleksandra ;

Wierzbowska, Agnieszka ;

Selleslag, Dominik ;

Jang, Jun Ho ;

Kumar, Rajat ;

Cavenagh, James ;

Schuh, Andre C. ;

Candoni, Anna ;

Recher, Christian ;

Sandhu, Irwindeep ;

Bernal del Castillo, Teresa ;

Al-Ali, Haifa Kathrin ;

Martinelli, Giovanni ;

Falantes, Jose ;

Noppeney, Richard ;

Stone, Richard M. ;

Minden, Mark D. ;

McIntyre, Heidi ;

Songer, Steve ;

Lucy, Lela M. ;

Beach, C. L. ;

Doehner, Hartmut .

BLOOD, 2015, 126 (03) :291-299

[9]

Fenaux P, 2007, BLOOD, V110, p250A

[10] Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making [J].

Ferrara, F. ;

Barosi, G. ;

Venditti, A. ;

Angelucci, E. ;

Gobbi, M. ;

Pane, F. ;

Tosi, P. ;

Zinzani, P. ;

Tura, S. .

LEUKEMIA, 2013, 27 (05) :997-999

← 1 2 →